Le rôle de la sérotonine sur le développement de traits anxieux : une étude
de trajectoire longitudinale by Farshadgohar, Tina
I 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
I 
 
 
Université de Montréal 
 
Le rôle de la sérotonine sur le développement de traits anxieux: une étude 
de trajectoire longitudinale 
 
par 
Tina Farshadgohar 
 
Département de Sciences Biomédicales Option Psychiatrie 
Faculté de médecine 
Mémoire présenté à la Faculté des études supérieures 
en vue de l’obtention du grade de 
Maître ès sciences (M. Sc.) 
en  Sciences biomédicales 
Option Sciences Psychiatriques 
Février, 2012 
 
© Tina Farshadgohar, 2012 
 
II 
 
 
Université de Montréal 
Faculté des études supérieures 
Ce mémoire intitulé : 
Le rôle de la sérotonine sur le développement de traits anxieux: une étude 
de trajectoire longitudinale 
 
présenté par : 
Tina Farshadgohar 
 
évalué par un jury composé des personnes suivantes : 
Graciela Piñeyro, Ph.D. 
président-rapporteur 
Linda Booij, Ph.D. 
directeur de recherche 
Jean R. Séguin, Ph.D. 
co-directeur 
Adrianna Mendrek, Ph.D. 
examinateur externe 
III 
 
Résumé 
Certains gènes, modulant la sérotonine (5-hydroxytryptamine, 5-HT), ont été 
associés aux tempéraments liés à l'anxiété. Une limitation dans la plupart de ces 
études est que les études sont de nature transversale et l'anxiété a été évaluée à un 
seul point dans le temps. De plus, seules quelques études ont été réalisées chez les 
enfants. Le but de la présente étude était d'étudier le rôle des gènes HTR2A et 
TPH2 dans le développement des trajectoires d’anxiété durant l’enfance. Les 
associations entre ces gènes, ces trajectoires, le diagnostic d’anxiété à l'âge adulte 
et les différences entre les sexes ont été examinées dans l'Étude Longitudinale des 
Enfants de Maternelle au Québec, composée de 3185 enfants recrutés en 1986-
1987. Leur anxiété a été cotée par leur professeur annuellement entre 6 et 12 ans. 
Ces cotes ont été modélisées en trajectoires comportementales. Les données 
genotypées de 5-HT, disponibles pour 1068 personnes, ont été analysées en 
utilisant les statistiques du Chi-carré, des régressions logistiques et des analyses 
de variance. Sur les 37 polymorphismes étudiés, plusieurs ont été associés à la 
trajectoire de forte anxiété, tels le 5-HTR2A (rs1328684, rs95534511, rs1745837, 
rs7984966, 7330636) et TPH2 (rs11179050, rs11179052, rs1386498). Bien que les 
trajectoires d’anxiété en enfance n’aient pas prédit le diagnostic d'anxiété à 21 
ans, les relations ont été trouvées entre ce diagnostic, HTR2A et les 
polymorphismes du nucléotide simple (PNS) de TPH2. On remarque que les PNS 
associés à l’anxiété durant l’enfance et l’âge adulte ne sont pas les mêmes. La 
force d'association entre les gènes étudiés et l'anxiété diffère entre les garçons et 
les filles. Cette étude est la première à identifier une association entre les variantes 
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TPH2, 5-HTR2A et les trajectoires d’anxiété en enfance. Les études futures 
devraient reproduire les résultats dans d'autres échantillons, enquêter sur 
l'interaction avec les facteurs de stress, et étudier la pertinence fonctionnelle de la 
PNS. 
Mots- Clés : La sérotonine, HTR2A, TPH2, l'anxiété, la trajectoire 
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SUMMARY 
A number of genes known to modulate serotonin (5-hydroxytryptamine, 5-HT) 
have been associated with anxiety-related temperaments. A limitation in most of 
these studies is that the studies are cross-sectional and anxiety has been measured 
at a single point in time. Furthermore, only a few studies have been done in 
children. The aim of the present study was to investigate the role of the HTR2A 
and TPH2 gene in the development of trajectories of anxiety in childhood/ 
adolescence. Associations between these genes, anxiety trajectories in childhood 
and anxiety diagnoses in adulthood were also investigated. Finally, gender 
differences were explored. Research questions were investigated in the Quebec 
Longitudinal Study of Kindergarten Children, consisting of 3185 boys and girls, 
selected in 1986-1987. Children`s anxiety was rated by their teacher every year 
between the age of 6 and 12 years. The ratings were modeled into behavioral 
trajectories. 5-HT genotyping data were available for 1068 cohort members. Data 
were analyzed using Chi-square statistics, logistic regressions and ANOVAs. Out 
of 37 investigated polymorphisms, several polymorphisms, such as 5-HTR2A 
(rs1328684, rs95534511, rs1745837, rs7984966, 7330636) and TPH2 
(rs11179050, rs11179052, rs1386498) were associated with a high anxiety 
trajectory. Though trajectories of high anxiety in childhood did not predict an 
anxiety diagnosis at age 21, relationships were found between HTR2A and TPH2 
SNPs and anxiety diagnosis at age 21. We note that the SNPs associated with 
anxiety were different between adults and children. The strength of association 
between the investigated genes and anxiety differed between boys and girls. This 
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is the first study reporting an association with some HTR2A and TPH2 variants and 
trajectories of anxiety in children. Future studies should replicate the findings in 
other samples, investigate the interaction with stressors, and study the functional 
relevance of the SNPs. 
Keywords: Serotonin, HTR2A, TPH2, anxiety, trajectory 
VII 
 
Table of contents 
JURY IDENTIFICATION PAGE      II 
RÉSUMÉ EN FRANÇAIS         III 
SUMMARY         V 
TABLE OF CONTENTS       VII 
LIST OF TABLES        X 
LIST OF FIGURES         XI 
LIST OF ABBREVIATIONS      XII 
DEDICATION        XIII 
ACKNOWLEDGEMENTS       XIV 
INTRODUCTION        15 
1. Anxiety         16 
       1.1 Anxiety trait versus anxiety disorders    16 
       1.2 Epidemiology of anxiety      17 
             1.2.1 General Anxiety Disorders      17 
             1.2.2 Panic Disorder       18 
      1.3 Heritability of anxiety disorders     19 
      1.4 Development of Anxiety; role of childhood factors  20                                             
      1.5 Neuroanatomy of anxiety      21 
           1.5.1 Hippocampus       22 
           1.5.2 The amygdala       22 
VIII 
 
           1.5.3 Limbic cortex       23 
1.6 Neurotransmitters mediating anxiety    23  
1.6.1 Gamma-amino butyric acid     24 
1.6.2 Noradrenalin       25 
2. Serotonin         25 
2.1 The serotonergic system      26 
2.1.1 The anatomy of the serotonergic system   26 
2.1.2 Serotonin synthesis and turnover    27  
2.1.3 Serotonin receptors      29  
2.1.4 The serotonin transporter     31 
2.1.5 Serotonin and behavior       32 
2.2 HTR2A and anxiety       33 
2.3 TPH2 and anxiety       34   
3. Anxiety, Serotonin and Sex      46  
4. Summary        47 
OBJECTIVE         49 
METHOD         50 
Study sample         51 
Developmental trajectories of anxiety     51 
Diagnostic Interview Schedule for Adults (DIS)    53 
Genotyping         53 
Statistics         54 
Continuous approach       54 
Categorical approach        55 
IX 
 
RESULTS         57 
Relationship between 5-HT genes and anxiety trajectories  58 
Continuous approach       58 
Effects of genotype on probability of high anxiety   58 
Categorical approach       62 
Effect of genotype on anxiety trajectory classification   62 
      Anxiety trajectories and clinical diagnosis in adulthood   65  
Gender differences        67 
      Effect of genotype on anxiety trajectory classification   67 
      Additive effect of gender on genotype and anxiety trajectories  69 
DISCUSSION        70 
REFERENCES CITED       79 
 
X 
 
List of tables 
Table-1: Summary of different subtypes of receptors with its distributions and 
effector mechanisms. 
Table 2-1: Summary of studies investigating the link between anxiety disorders 
(social and specific phobia, OCD, GAD, SAD, PD) and TPH2 polymorphisms. 
Table 2-2: Summary of studies investigating the link between panic disorder and 
TPH2 polymorphisms.  
Table 2-3: Summary of studies investigating the link between OCD and TPH2 
polymorphisms. 
Table 3: Distribution of genotype frequencies of HTR2A and TPH2 
polymorphisms as a function of anxiety trajectory.  
Table 4:  Results of the logistic regression analyses, predicting anxiety diagnosis 
in adulthood from HTR2A and TPH2 genotypes.  
Table 5: Distribution of genotype frequencies of the HTR2A and TPH2 
polymorphisms within low, moderate and high anxiety trajectories in boys 
(percentage of genotype frequency), p < .05.  
Table 6: Distribution of genotype frequencies of the HTR2A and TPH2 
polymorphisms within low, moderate and high anxiety trajectories in girls 
(percentage of genotype frequency), p < .05.  
XI 
 
List of figures 
Figure 1: Biosynthesis of 5-HT.             
Figure 2:  Schematic illustration of serotonergic synapse. After tryptophan is 
converted to 5-HT, 5-HT is packaged into storage vesicles or passes through a 
membrane by the 5-HT transporter (SERT). Then 5-HT stimulates its post 
synaptic receptors.          
Figure 3: Schematic illustration of the 5-HT transporter. First, sodium binds to  
5-HT and both of them bind to the transporter followed by a chloride ion. Then, 
neurotransmitters and ions release into the cytoplasm of the neuron. The 
reorientation of the carrier is occurring by binding intracellular potassium into the 
transporter and releasing potassium outside the cell. 
Figure 4: Development trajectories of anxiety, between age of 6 and 12 years. 
Figure 5-1: Probability to be in the high anxiety trajectory, as a function of 5-HT2A 
genotype rs1328684 (a) and rs95534511 (b). Probabilities are expressed in 
percentages.  
Figure 5-2:  Probability to be in the high anxiety trajectory, as a function of TPH2 
genotype rs11179050 (a) and rs11179052 (b). Probabilities are expressed in  
percentages.
XII 
 
List of abbreviations 
5-HT: 5-hydroxytryptamine, serotonin 
AADC: aromatic L-amino acid decarboxylase 
DIS: Diagnostic Interview Schedule 
DRN: dorsal raphe nuclei 
ELEMQ: Étude Longitudinal des Enfants de Maternelle au Québec 
GABA: gamma-aminobutyric acid 
GAD: general anxiety disorders 
HTR2A: hydroxytryptamine receptor 2a 
LD: linkage disequilibrium  
MRI: magnetic resonance imaging 
OCD: obsessive-compulsive disorder 
PD: panic disorder 
PET: positron emission tomography 
PTSD: post-traumatic stress disorder 
SAD: social anxiety disorder 
SNP: single-nucleotide polymorphism 
SSRI: selective serotonin reuptake inhibitor 
TPH: tryptophan hydroxylase 
 
 
 
 
XIII 
 
 
 
 
 
 
 
 
To the bright memory of my 
husband 
 
 
 
 
 
 
 
 
 
 
XIV 
 
Acknowledgements  
 I would like to dedicate my thesis in memory of my beloved husband Mehdi, who 
passed away before my final submission, his love and lifelong support has enabled 
me to achieve my goals and finish what I have started.                                                                           
It would not have been possible to write this master thesis without the help and 
support of the kind people around me, to only some of whom it is possible to give 
particular mention here. 
I would like to express my appreciation to my primary supervisor Dr. Linda 
Booij, for giving me the opportunity to be part of her laboratory group. This thesis 
would not have been possible without her help, support and patience. Also special 
thanks to my co-supervisor Dr. Jean R. Séguin, Dr. Graciela Piñeyro (president of 
the thesis committee) and Dr. Adrianna Mendrek (external examiner) for their 
time and patience. It has been an honor to work with all of you. 
The most special thanks go to my parents for giving me your unconditional 
support and love through all this long process to complete my thesis. 
 
 
  
15 
 
 
 
 
 
 
 
 
Introduction 
 
 
 
 
 
 
 
 
 
16 
 
1. Anxiety 
1.1 Anxiety trait versus anxiety disorders 
Anxiety and fear are human emotions that have a protective role in order 
to avoid situations which cause injury, pain or even death (Moffitt, 2005; Rex, 
2010). Although anxiety is a biologically normal and adaptive condition, it could 
be pathological and interfere with the capability to successfully manage numerous 
challenges and/or stressful events, and even alter the body condition (Steimer, 
2002). Acute or immediate levels of anxiety could be defined as state anxiety; 
whereas trait anxiety is a long-term anxiety response predisposition to events 
(Perez-Edgar & Fox, 2005). Certain personality traits, especially high levels of 
neuroticism (a tendency to experience negative emotions, thereby having a greater 
chance of feeling anxious, sad and angry in normal situations) is an important risk 
factor for the development of an anxiety disorder  (Hettema, Neale, Myers, 
Prescott, & Kendler, 2006). 
The development of human anxiety disorders is based on three interacting 
sets of vulnerability factors: 1) a generalized psychological vulnerability: largely 
resulting from early life experiences 2) a specific psychological vulnerability: 
mainly focused on specific events or situations and 3) a generalized biological 
vulnerability: based on genetic origins (Barlow, Grenyer, & Ilkiw-Lavalle, 2000; 
Steimer, 2002). 
According to the Diagnostic and Statistical Manual of Mental Disorders 
(fourth edition, test revision) (DSM-IV-TR) anxiety disorders are divided into 
general anxiety disorders (GAD), social anxiety disorder (SAD), panic disorder 
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(PD), specific and social phobias, obsessive-compulsive disorders (OCD) and 
post-traumatic stress disorder (PTSD) (American Psychiatric & American 
Psychiatric Association. Task Force on, 2000). 
Anxiety-related behaviors seem to be controlled by the distribution and 
interconnection of neural circuits in the brain (Lowry & Hale, 2010).  A variety of 
neuroendocrine, neurotransmitter and neuroanatomical alterations could occur in 
anxiety disorders (Martin, Ressler, Binder, & Nemeroff, 2009). In the following 
sections of my thesis, the neural and anatomical systems involved in modulating 
anxiety will be briefly discussed. 
1.2 Epidemiology of anxiety 
Anxiety disorders are among the most prevalent psychiatric disorders with 
an approximate lifetime prevalence of 28.8% and an approximate 12-month 
prevalence of 18.1% in the general population (Kessler, Berglund, et al., 2005; 
Kessler, Chiu, Demler, Merikangas, & Walters, 2005). Epidemiological studies 
demonstrated that females are more likely to develop PD (7.7%) and GAD (6.6%) 
than men (2.9% and 3.6 %, respectively). The prevalence of PTSD is also higher 
in females than in males (12.5% vs. 6.2%)(Kessler et al.,1994). This thesis 
focuses on GAD and PD. 
1.2.1 General Anxiety Disorders 
According to the national comorbidity survey (NCS) in United States, the 
lifetime prevalence of GAD is approximately 5.7 % (Kessler, Berglund, et al., 
2005). According to the DSM-IV-TR (American Psychiatric & American 
Psychiatric Association. Task Force on, 2000)  GAD is characterized by excessive 
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anxiety and worry, occurring more days than not for a period at least 6 months, 
about a number of events or activities and the person usually finds it difficult to 
control the worry (American Psychiatric & American Psychiatric Association. 
Task Force on, 2000). There are six symptoms for GAD: restlessness, being easily 
fatigued, irritability, muscle tension, difficulty concentrating and sleep 
disturbance (American Psychiatric & American Psychiatric Association. Task 
Force on, 2000). In order to meet the formal diagnostic criteria, at least three of 
these symptoms need to be present and they must affect social or occupational 
functioning. Most of the people with GAD report that they have felt anxious and 
nervous all their life (American Psychiatric & American Psychiatric Association. 
Task Force on, 2000). More than half of individuals presenting for treatment 
report onset in childhood and onset in adulthood (American Psychiatric & 
American Psychiatric Association. Task Force on, 2000). GAD has a chronic but 
fluctuating course and often worsens during periods of stress (American 
Psychiatric & American Psychiatric Association. Task Force on, 2000). 
1.2.2 Panic Disorder 
The lifetime prevalence of PD is estimated to be 4.7% in the United States 
(Kessler, Chiu, et al., 2005). According to the DSM-IV-TR, one-year prevalence 
rates are approximately 1% and 2 % (American Psychiatric & American 
Psychiatric Association. Task Force on, 2000). PD implicates recurrent, 
unexpected panic attacks followed by at least one month of persistent concern 
about having another panic attack, worry about the consequences of the panic 
attacks and/or significant change in behavior related to the attacks (American 
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Psychiatric & American Psychiatric Association. Task Force on, 2000). The 
symptomology associated with this disorder includes shortness of breath, feeling 
of choking, palpitation, sweating, trembling or shaking, a feeling of losing control 
or going crazy and fear of dying.  PD is associated with the discrete period of 
intense fear in the absence of real danger and having at least four of these 
symptoms (American Psychiatric & American Psychiatric Association. Task 
Force on, 2000).The age of onset lies between late teenage years and the mid-30s, 
with the first peak in late adolescence and a second smaller peak in the mid-30s.  
However, the age of onset could differ considerably, from the beginning of 
childhood until after age 45 (American Psychiatric & American Psychiatric 
Association. Task Force on, 2000). 
1.3 Heritability of anxiety disorders 
Anxiety disorders have been shown to be heritable. Family studies 
compare the phenotype prevalence among affected members of family with 
unaffected members (Na, Kang, Lee, & Yu, 2011). Several family studies have 
demonstrated an increasing risk for PD (5.7%-17.3%) between affected 
individuals’ relatives and unaffected relatives (Goldstein et al., 1994; Horwath et 
al., 1995; Maier, Lichtermann, Minges, Oehrlein, & Franke, 1993; Noyes et al., 
1986). A meta-analysis confirmed a heritability across GAD, OCD, PD and 
phobias in a moderate range (30%-40%) (Hettema, Neale, & Kendler, 2001). 
Moreover, in a large population-based female adult twins sample, comparing 
monozygotic with dizygotic twins, Kendler et al. estimated the heritability at 
approximately 30-40% for both GAD, PD and phobias (agoraphobia, social 
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phobia, situational phobia and simple phobia) (Kendler, Neale, Kessler, Heath, & 
Eaves, 1992, 1993). These results were confirmed in a later study, showing 
similar estimations of hereditability for men in GAD and PD (Scherrer et al., 
2000). A recent adult twin-study analysis, consisting of more than 5,000 twins, 
estimated a heritability of 28% for PD (Hettema, Prescott, Myers, Neale, & 
Kendler, 2005). 
Finally, a high familial and genetic connection has been demonstrated for 
anxiety-related personality traits (Smoller et al., 2001; Weissman et al., 2000). 
Thus, genetic factors clearly contribute to the pathogenesis of anxiety disorders. 
1.4 Development of Anxiety; role of childhood factors 
Longitudinal epidemiological studies have shown that high and persisting 
levels of anxiety or depressive disorders in childhood or early adolescence are 
strong predictors of anxiety diagnosis in adulthood (Beesdo, Knappe, & Pine, 
2009; Bittner et al., 2007; Pine, Cohen, Gurley, Brook, & Ma, 1998). For 
instance, in an epidemiological study, Pine et al. selected a sample of 776 young 
people who received DSM-based psychiatric assessment between1983-1992. 
They showed that an anxiety disorder during adolescence predicted recurrent 
anxiety disorders in early adulthood (Pine et al., 1998). 
While anxiety in childhood could predict anxiety disorders in adulthood, 
other longitudinal studies have shown that a lack of anxiety (fearlessness) could 
be a predictor of aggressive problems later in life. Specifically, fearlessness at age 
3 was associated with  aggression problems at age 11 (Raine, Reynolds, Venables, 
Mednick, & Farrington, 1998) and the children from that longitudinal study who  
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later became criminals showed significantly reduced fear conditioning in 
adulthood (Gao, Raine, Venables, Dawson, & Mednick, 2010).  An animal study 
investigated underlying genetic mechanisms of a lack of fear. By globally 
disrupting the function of the HTR2a receptor Weisstaub et al. demonstrated an 
association between fearlessness behaviors and 5-HTR2A polymorphisms in mice 
(for a description of this gene in greater detail- see page 33) (Weisstaub et al., 
2006). No other animal studies or any human studies investigated the genetic 
underpinnings of fearlessness and especially not in the context as predictor of 
future problems, such as aggression, and thus the relevance for humans is not 
known. However, the above mentioned studies suggest the importance of 
measuring both high and low anxiety at an early age and to identify genetic 
mechanisms, since both sides of the spectrum may predict future maladaptive 
outcome. 
1.5 Neuroanatomy of anxiety 
Anxiety has a complex function which does not depend on specific brain 
areas executing a unique function, so the interaction of several brain regions has 
been proposed to be responsible for the symptoms (Martin et al., 2009). The 
imbalance of activity in the “emotion center” of the brain is thought to be 
responsible for the symptoms of anxiety disorders (Martin et al., 2009). The 
limbic system and associated paralimbic brain structures are known to be a set of 
brain regions related to emotional-processing and involved in the mediation of 
fear(Martin et al., 2009). In a mixed sample of anxiety disorder patients 
(obsessive-compulsive disorder, simple phobia or posttraumatic stress disorder) 
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(using PET), it was shown that elements of the paralimbic belt together with right 
inferior frontal cortex and subcortical nuclei mediate symptoms across different 
anxiety disorders (S.L. Rauch, C.R. Savage, N.M. Alpert, A.J. Fischman, & M.A. 
Jenike, 1997). The hippocampus, amygdala, and limbic cortex are the most 
important brain regions modulating anxiety. 
1.5.1 Hippocampus 
The hippocampus has an important role in memory consolidation. The 
hippocampus is partly regulated by the hypothalamus-pituitary-adrenal (HPA) 
axis, and has an inhibitory control over this system (Martin et al., 2009). 
Hippocampal volume and neurogenesis involved in stress and volume changes 
were shown to be related to anxiety disorders (Bonne et al., 2008; Gorman & 
Docherty, 2010; Villarreal et al., 2002). A meta-analysis revealed a significantly 
reduced hippocampal volume (bilateral) in adults diagnosed with PTSD compared 
with healthy controls  (Kitayama, Vaccarino, Kutner, Weiss, & Bremner, 2005). 
1.5.2 The amygdala 
The amygdala is formed of multiple subnuclei, where each nucleus has a 
separate pattern of afferent and efferent projections (Martin et al., 2009). This 
complex structure is involved in the expression of fear and in fear conditioning, 
environment-specific defensive behaviors (Etkin, 2010). Also, the amygdala plays 
a role in the realization of emotional and fear-related memories (Martin et al., 
2009). Particularly, basolateral complex and the central nucleus are involved in 
anxiety (Heimer, Harlan, Alheid, Garcia, & de Olmos, 1997). Using Magnetic 
Resonance Imaging (MRI), MacMillan et al. showed an association between 
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increases in ratio of the left and right regions of amygdala: hippocampal volume 
and severity of anxiety (MacMillan et al., 2003). Another MRI study found that 
right and total amygdala volumes were significantly larger in participants with 
GAD compared to healthy controls (De Bellis et al., 2000). 
1.5.3 Limbic cortex 
The limbic cortex, which includes the insular cortex and cingulate cortex, 
processes internal bodily state and pain-related sensory and affective information, 
motivation and mood  (Etkin, 2010). Rauch et al. measured relative regional 
cerebral blood flow (rCBF) by Positron Emission Tomography (PET) in 23 
participants suffering from anxiety disorders (OCD, simple phobia, PTSD) (S. L. 
Rauch, C. R. Savage, N. M. Alpert, A. J. Fischman, & M. A. Jenike, 1997). They 
showed increased activation in response to disorder relevant emotional stimuli 
(relative to neutral stimuli) in different regions of the brain, including the bilateral 
insular cortex. In their previous study, they had found bilateral insula activation 
for both simple phobia and PTSD (Rauch et al., 1995; Rauch et al., 1996) bilateral 
anterior cingulate activation for simple phobia and PTSD and only left anterior 
cingulate activation for patients with OCD (Rauch et al., 1994). Thus, these 
findings suggest an implication of the limbic cortex in a variety of anxiety 
disorders. 
1.6 Neurotransmitters mediating anxiety 
Neurotransmitters are chemical messengers involved in the transmission 
of a nerve impulse from one cell to another. They are formed inside the 
presynaptic neuron in vesicles (small membrane-bound sacks). After activating a 
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neuron, by an exocytosis process these vesicles release their content in the 
synapse. The most important neurotransmitter systems that are implicated in 
anxiety include the GABAergic system, the noradrenergic system and the 
serotonergic system (Rex, 2010). 
1.6.1 Gamma-amino butyric acid 
Amino butyric acid (GABA) is the most abundant inhibitory 
neurotransmitter in the brain (Steimer, 2002) which tends to be deficient in 
anxiety disorders.  There are 3 GABA receptor subtypes, GABAA, GABAB and 
GABAC (Bormann, 2000).  The GABAA receptor is known to have a major role in 
anxiety, epilepsy, alcoholism and other psychiatric disorders (Smith, 2001). 
GABAA receptors contain 5 protein subunits (α1, α2, α3, α4, α6) which their 
distribution is heterogeneous within regions of the brain.  Receptor subunit 
configuration determines the receptor`s sensitivity to different ligands and its 
diversity of function (Lydiard, 2003).  The GABAA receptor is often the target of 
pharmacologic agents, including the neurosteroids and benzodiazepines.  The 
relevance of the GABA system for anxiety is widely supported by 
pharmacological studies, showing that medication that impact GABA receptors 
system (i.e. GABA A receptors), such as benzodiazepines, are effective in the 
treatment of anxiety (Nemeroff, 2003; Steimer, 2002). Moreover, a number of 
studies have demonstrated that, compared to healthy controls, patients with 
anxiety disorders (panic disorder, PTSD and GAD) have lower benzodiazepine 
binding in various brain regions as assessed by several researches(J. D. Bremner, 
Innis, Southwick, et al., 2000; Goddard et al., 2001; Malizia et al., 1998; Tiihonen 
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et al., 1997). Also other GABAergic agents, have been evaluated for therapeutic 
options (Nemeroff, 2003). Hence, GABA system is an important target in the 
treatment of anxiety disorders. 
1.6.2 Noradrenalin 
The neurotransmitter noradrenalin is closely involved in a range of 
psychological processes. Consistent with this, alterations in this neurotransmitter 
system have been implicated in a range of psychiatric disorders, including 
anxiety. Preclinical studies in rats have shown associations between anxiety and 
high levels of noradrenalin in several brain regions, including the hypothalamus 
and amygdala  (Steimer, 2002). Moreover, Bremner et al., showed that, 
yohimbine administration (which is an α2-antagonist) that increases brain 
noradrenalin release and results in symptoms of PTSD and fear and anxiety in 
PTSD patients) was decreased in prefrontal, temporal, orbitofrontal, and parietal 
cortex in patients with Vietnam combat-related PTSD, compared to healthy 
controls (Bremner et al., 1997). This suggests that yohimbine administration in 
normal controls may be associated with lower levels of norepinephrine release in 
central brain regions than in patients with PTSD. Thus, noradrenaline appears to 
play an important role in the etiology and treatment of anxiety disorders. 
2. Serotonin 
The neurotransmitter serotonin controls anxiety with different distinct 
mechanisms. For instance, the ascending serotonin pathway (originated from 
dorsal raphe nuclei-DRN) facilitates conditioned fear, while the DRN-
periventricular pathway inhibits reaction to danger (Steimer, 2002).  Serotonin is 
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the most widely investigated neurotransmitter in relation to mental disorders. 
Moreover, serotoninergic antidepressants, in particular Selective Serotonin 
Reuptake Inhibitors (SSRIs), are the most widely prescribed medication for 
internalizing disorders, including anxiety disorders. For the purpose of the present 
thesis, this neurotransmitter system will be described in greater detail in the next 
section. 
2.1 The serotonergic system 
2.1.1 The anatomy of the serotonergic system 
Serotonin (or 5-hydroxitryptamine, 5-HT) is a key neurotransmitter which 
is developed and expressed early in humans (Whitaker-Azmitia, 2010). The 
location of serotonergic cell bodies in the brain is limited to the raphe nuclei, 
caudal to the isthmus, but serotonergic fibers project to most parts of the brain. 
Raphe nuclei are located near the midline of the brainstem with its entire rostro-
caudal extension (Hornung, 2003). There are two groups of serotonergic neurons: 
superior group (superior brain stem group) and inferior group (inferior brain stem 
group). The superior raphe group is mainly divided into caudal linear nucleus, 
dorsal raphe nuclei and median raphe nucleus. The caudal linear nucleus is the 
most rostral nucleus of the raphe nuclei containing 5-HT-synthesizing neurons, 
while the largest population of serotonergic neurons in human is located in the 
dorsal raphe (Hornung, 2003).  Most of the serotonergic fibers in the superior 
group of raphe nuclei project to the forebrain (Tork, 1990).  Also, the dorsal raphe 
nucleus and caudal linear nucleus (rostral division of superior group), project to 
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the basal ganglia, cerebral cortex and median raphe nuclei (caudal division), 
innervates the amygdala (Jacobs & Azmitia, 1992). 
The inferior raphe group is divided into nucleus raphe magnus, nucleus 
raphe obscurus, and nucleus raphe pallidus, all of which project to the spinal cord.  
In the central nervous system, the inferior parts contain only 15% of the total 5-
HT  production  (Jacobs & Azmitia, 1992). 
2.1.2 Serotonin synthesis and turnover 
The physiological effects of 5-HT are mediated by a variety of proteins 
that regulate its synthesis, release, reuptake and degradation.  5-HT is a biogenic 
monoamine transmitter which contains only one ethylamine linked to an aromatic 
ring system (Hasegawa & Nakamura, 2010).  In serotonergic cells, 5-HT is 
derived from tryptophan, an essential amino acid, which is actively transported 
into brain (Hasegawa & Nakamura, 2010). 5-HT cannot pass the brain barrier by 
itself, but its precursor L-tryptophan can pass by a facilitated diffusion process, 
through the competition between free tryptophan and large neutral amino acids 
(Buckworth & Dishman, 2002). 5-HT is synthesized by a short metabolic pathway 
consisting of two enzymes: 1) tryptophan hydroxylase (TPH) and 2) aromatic- L-
amino acid decarboxylase (AADC) (Hasegawa & Nakamura, 2010). Tryptophan 
hydroxylase is a biopterin-dependent monooxygenase (Kaufman, 1962) which is a 
rate-limiting step in the pathway (Fitzpatrick, 1999; Grahame-Smith, 1964; 
Ruddick et al., 2006). Tryptophan hydroxylase exists in two isoforms: TPH1and 
TPH2. The AADC catalyzes the decarboxylation of 5-hydroxy-L-tryptophan, 
yielding in 5-HT producing cells (Hasegawa & Nakamura, 2010; Voltattorni, 
28 
 
Minelli, & Turano, 1971) (Figure 1).  The synthesis of 5-HT is dependent on the 
tryptophan plasma concentration. A tryptophan-free diet causes a decrease in 
tryptophan’s level in plasma and brain which in turn leads to a decrease in 
concentration of 5-HT (Biggio, Fadda, Fanni, Tagliamonte, & Gessa, 1974; Booij, 
Van der Does, & Riedel, 2003).  Finally, a decrease in extracellular 5-HT will 
have consequences on neural activity (Feenstra & van der Plasse, 2010). 
 
Figure 1: Biosynthesis of 5-HT. 
After synthesizing, 5-HT is stored in vesicular pools or is released to the 
extracellular space and be transferred to the receptors (Figure 2). 
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Figure 2:  Schematic illustration of serotonergic synapse. After tryptophan is 
converted to 5-HT, 5-HT is packaged into storage vesicles or removed from the 
synaptic cleft by the by the 5-HT transporter (SERT). Monoamine oxidase (MAO) 
converted 5-HT to 5-hydroxyindoleacetic acid (5-HIAA). Inter-synaptic 5-HT 
stimulates its post synaptic receptors (5-HT1-7). Figure based on the Handbook of 
behavioral neurobiology of 5-HT (Müller & Jacobs, 2009). 
2.1.3 Serotonin receptors 
5-HT receptors are distributed in the brain and body in many cell types.  
There are at least 14 distinct receptors that are classified into seven groups, 5-HT1-
7 that are mediating 5-HT signaling (Figure 2) (Barnes & Sharp, 1999; Hoyer, 
Hannon, & Martin, 2002). 5-HT receptors are all coupled G-proteins (guanine 
nucleotide-binding protein), except for 5-HT3 receptor which is a ligand-gated ion 
channel. 
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Table-1 Summary of different subtypes of 5-HT receptors with their distributions 
and effectors mechanisms (Siegel et al., 1999). 
 
Receptor Human locus Distribution Effector mechanism 
5-HT1A 5q11.2–13 Hippocampus, amygdala, septum, 
entorhinal cortex, hypothalamus, raphe 
nuclei 
Inhibition of adenylyl cyclase, 
opening of K+ channels 
5-HT2A 13q14–21 Claustrum, cerebral cortex, olfactory 
tubercle, striatum, nucleus accumbens 
Stimulation of phosphoinositide 
-specific phospholipase C, 
closing of K+ channels 
5-HT2B 2q36.3–37.1 ? b Stimulation of phosphoinositide 
-specific phospholipase C 
5-HT2C Xq24 Choroid plexus, globus pallidus, 
cerebral cortex, pallidus,hypothalamus, 
septum, substantia nigra, spinal cord 
Stimulation of phosphoinositide 
- specific phospholipase C 
5-HT3 ? Hippocampus, entorhinal cortex, 
amygdala, nucleus accumbens, solitary 
tract nerve, trigeminal nerve, motor 
nucleus of the dorsal vagal nerve, area 
postrema, spinal cord 
Ligand-gated cation channel 
5-HT4 ? Hippocampus, striatum, olfactory 
tubercle, substantia nigra 
Stimulation of adenylyl cyclase 
5-ht5A 7q36 ? Inhibition of adenylyl cyclase 
5-HT5B 2q11–13 ? ? 
5-ht6 ? ? Stimulation of adenylyl cyclase 
5-HT7 10q23.3–24.3 Cerebral cortex, septum, thalamus, 
hypothalamus, amygdala, superior 
colliculus 
Stimulation of adenylyl cyclase 
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a) Lower-case appellations are used in some cases because the functions mediated by these receptors in intact tissue are 
presently unknown. 
b) Question marks mean that presently no studies have examined this, and thus the locus or distribution is unknown 
2.1.4 The serotonin transporter 
The 5-HT transporter is a monoamine integral membrane protein (known 
as the SERT). In the brain, the highest concentration of 5-HT transporter is in the 
midbrain, thalamus and basal ganglia, while the lowest concentration is in the 
cortex (Frankle et al., 2006; Houle, Ginovart, Hussey, Meyer, & Wilson, 2000).  
The function of the 5-HT transporter is to move 5-HT from the synaptic space 
back into presynaptic neurons to be re-used again (Figure 2). This protein 
regulates serotonergic system and its receptors by modulating extracellular 5-HT 
concentration (Murphy, Lerner, Rudnick, & Lesch, 2004).  The 5-HT transporters 
carry the preponderance of extracellular 5-HT back into the serotonergic neuron. 
These transports are dependent on extracellular concentration of Na+/CL – (Figure 
3). 
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Figure 3: Schematic illustration of the 5-HT transporter. First, sodium binds to 5-
HT and both of them bind to the transporter followed by a chloride ion. Then, 
neurotransmitters and ions release into the cytoplasm of the neuron. The 
reorientation of the carrier is occurring by binding intracellular potassium into the 
transporter and releasing potassium outside the cell. Figure based on (Cao, Li, 
Mager, & Lester, 1998). 
2.1.5 Serotonin and behavior 
Both animal and human studies have shown that 5-HT plays a significant 
role in a wide range of psychiatric disorders such as anxiety, aggression, suicide, 
as well as in certain personality traits, such as neuroticism. Fourteen distinct 
receptors mediate signalization of 5-HT (Barnes & Sharp, 1999; Bockaert, 
Claeysen, Dumuis, & Marin, 2010; Hoyer et al., 2002). Alteration of gene 
expression in these proteins in the brain could have important consequences for 5-
HT synaptic availability or signaling in different receptors (O'Leary & Cryan, 
2010). Thus, these changes in gene expression, in turn influence the serotonergic 
system, which may  affect  behaviors (O'Leary & Cryan, 2010). 
In the past decade, numerous studies have tested associations between 5-
HT genes and anxiety traits or anxiety disorders. One of the first studies 
investigating the link between 5-HT genes and behavior showed an association 
between the short variant of the 5-hydroxytryptamine-linked polymorphic region 
(5-HTTLPR) and anxiety-related personality traits (neuroticism) (Lesch et al., 
1996). Since that time, numerous 5-HT genes have been associated with anxiety, 
though results are not entirely consistent. Among the many genes that have been 
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identified and investigated in association with behaviors, of particular interest are 
5-hydroxytryptamine receptor 2A (HTR2A) and Tryptophan hydroxylase-2 (TPH2) 
polymorphisms. That is because HTR2A and TPH2 are molecules strongly 
involved in 5-HT regulation that in turn influence the production of 5-HT in the 
brain. These genes and their associations with behaviors are described and 
investigated in greater detail in this thesis. 
2.2 HTR2A and anxiety 
The 5-HTR2A gene is located on chromosome 13q14-q21 in humans and 
consists of three exons separated by two introns (Chen, Yang, Grimsby, & Shih, 
1992). A number of single nucleotide polymorphisms have been characterized in 
this gene, including T102C and –1438A/G in the promoter region (Li, Duan, & 
He, 2006). 
Wesstaub et al. generated mice that were genetically modified with global 
disruption of 5HTR2A signaling capacity (htr2a -/- mice).  In these mice, anxiety 
traits decreased, while after some restoration mainly in layer V of the cortex for 5-
HTR2A, the anxiety phenotype has been reversed (Weisstaub et al., 2006). This 
study suggests that 5HTR2A plays an important role in the modulation of conflict 
anxiety. Also, 5-HTR2A has been shown to be involved in the pathophysiology of 
anxiety disorders in dogs; dogs with anxiety disorders had Lower 5-HT2A receptor 
binding index in the left and right frontal cortices than normally-behaving dogs 
(Vermeire et al., 2009). 
In humans, one study demonstrated an association between PD symptom 
severity and the number of T alleles in HTR2A polymorphisms which 15 
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polymorphic SNPs of the HTR2A gene were associated with clinical diagnosis of 
PD and severity of PD (Unschuld et al., 2007). 
Another study found an association between the promoter region of HTR2A (1438 
G/A, rs6311) and OCD symptomatology (Walitza et al., 2011). Specifically, 
within the OCD patient group, the A allele was associated with higher scores on 
the Y-BOCS scores and a 2.5 year earlier age of onset. No other human studies 
were found that investigated the association between the 5-HT2A gene and 
anxiety. With regard to other psychiatric disorders such as schizophrenia, 
attention deficit hyperactivity disorder, suicide, eating disorders, and Alzheimer's 
disease, the association between the HTR2A gene and disease have been 
inconsistent (Norton & Owen, 2005). 
2.3 TPH2 and anxiety 
Tryptophan hydroxylase (TPH) has two isoforms, TPH1 and TPH2.  
Whereas TPH1 is found mainly expressed in the periphery, a second isoform, 
TPH2, is exclusively found in the brain (Hasegawa & Nakamura, 2010). The 
TPH2 gene is located on chromosome 12q21.1 and consists of 11 exons (Booij et 
al., 2011). A study in inbred mice demonstrated lower (50%-70%) 5-HT synthesis 
in the frontal cortex and stratum in homozygous carriers of the 1473G mutation 
comparing into homozygous mice carriers of the 1473C mutation (Zhang, 
Beaulieu, Sotnikova, Gainetdinov, & Caron, 2004). The relevance of this 1473G 
mutation for humans was supported by the initial observation of an association 
between the human analogue of this mutant and increased prevalence of 
depression (Zhang et al., 2004).  However, in spite of these associations the 
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prevalence of this human mutant could not be detected in other human 
populations (see Booij et al., 2011 for an overview). 
The relevance of other TPH2 variants for human brain 5-HT synthesis was 
investigated in a recent study. Specifically, Booij et al. (Booij et al., 2011) 
investigated the possible role of intronic TPH2 variants for human brain 5-HT 
synthesis in the orbitofrontal cortex, using in vivo positron emission tomography 
measures of 5-HT synthesis in 70 participants including 54 with no current mental 
disorder. They found dose-effect relationships for two variants which have 
previously been associated with suicide, demonstrating the relevance of the TPH2 
gene variation for 5-HT synthesis in the human brain. 
Compared to the 5-HT2A gene, much more studies are available that have 
examined the TPH2 gene in relation to mental health, including studies in anxiety 
disorder patients. A summary of these studies can be found in table 2 (Ottenhof, 
Ruhé, Lévesque, Booij, & TPH2 and psychiatric morbidity, Manuscript 
submitted). The TPH2 gene has also been implicated as a candidate in other 
neuropsychiatric phenotypes including; suicidal behavior, depression and 
attention deficit/hyperactivity disorder (Ottenhof, Ruhé, Lévesque, & Booij, 
Manuscript submitted; Pavlov, Chistiakov, & Chekhonin, 2012).  
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Table 2-1: Summary of studies investigating the link between anxiety disorders 
(social and specific phobia, OCD, GAD, SAD, PD) and TPH2 polymorphisms. 
 
First 
author; 
year 
Participants 
(male/female; mean 
age) 
n Measure
ments 
SNP Association 
Lin; 
2009 
Han Chinese women 
(29.8  yrsa) with 
prepartum, 
postpartum and 
persistent depression, 
social and specific 
phobia, OCD, or 
generalized anxiety 
disorder diagnosed 
using SADS 
 
Controls (women; 
29.7 yrs) with no 
history of depression 
or anxiety 
117 
 
 
 
 
 
 
 
83 
Patients 
(pts) vs 
controls 
 
LDb 
C2755A 
 
 
rs4570625 
rs11178997 
rs11178998 
rs11179003 
rs17110747 
Frequency of the AC genotype 
was higher in pts relative to 
controls 
No sig. differences in genotype 
distribution in pts. relative to  
controls 
Higher frequency of the 
rs4570625- rs11178997 
- rs11178998-C2755A G-T-A-A 
haplotype in pts  relative 
controls (though stricter 
permutation tests did not show 
significance) 
Weak LD between C2755A and 
C10662T. LD between most of 
the adjacent markers. 
Fur- 
mark;  
2009 
Medication-free pts 
(14/20; 37.6±8.6 yrs) 
diagnosed with social 
anxiety disorder 
(SAD) (25 
generalized, 9 non 
generalized) using 
SCID. 7 pts had a 
34 
 
 
 
 
 
 
 
Pts vs 
controls 
 
fMRI 
responses 
to an 
emotional 
face-
rs4570625 
 
No sig. differences in allele 
frequency in pts.  relative 
controls 
T allele carrying patients and 
controls (controls only at the 
uncorrected level) show a higher 
left amygdala response than GG 
homozygotes 
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comorbid anxiety 
disorder: specific 
phobia (n=5), panic 
disorder and 
agoraphobia. 
Exclusion criteria: 
SAD treatment of 
social anxiety 
disorder in 6 months 
preceding the study, 
current serious or 
dominant psychiatric 
disorder other than 
SAD, chronic use of 
prescribed 
medication, alcohol or 
drug abuse, 
pregnancy, 
menopause, left 
handedness, previous 
PET examination and 
any somatic or 
neurologic disorder 
that could be expected 
to influence the 
outcome of the study. 
Healthy controls (9/9; 
34.5±9.5 yrs). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
18 
processing 
task: 
- pts vs 
controls 
- 
subgroups 
of patients 
and 
controls 
with 
different 
genotypes 
T allele carrying patients show a 
higher left amygdala response 
than GG homozygote controls 
 
Carrying the T allele was a 
significant predictor of reactivity 
in the left amygdala in the whole 
sample and in SAD patients 
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Fur- 
mark; 
2008 
 
Medication-free 
patients (9/16; 
35.6±10.7 yrs) 
diagnosed with SAD 
(18 generalized, 7 
nongeneralized) using 
SCID. 8 patients had a 
comorbid anxiety 
disorder: specific 
phobia (n=5), 
generalized anxiety 
disorder (n=2), panic 
disorder (n=1) and 
mild posttraumatic 
stress disorder (n=1). 
Exclusion criteria: 
SAD treatment of 
social anxiety 
disorder in 6 months 
preceding the study, 
current serious or 
dominant psychiatric 
disorder other than 
SAD, chronic use of 
prescribed 
medication, alcohol or 
drug abuse, 
pregnancy, 
menopause, left 
handedness, previous 
 
 
 
PET scan 
during 
stressful 
speaking 
task 
 
Responder
s vs non-
responders 
 
Post- vs 
pretreatme
nt 
 
rs4570625 
 
 
T allele carriers showed a 
smaller rCBF decrease from pre- 
to posttreatment (8 weeks) with 
placebo in the right and left 
(puncorr = 0.009) amygdala. 
 
Pre- to posttreatment differences 
in amygdala rCBF were only 
significantly reduced in 
homozygotic G allele patients 
 
The rs4570625 SNP was a 
predictor for clinical placebo 
response on day 56.  
 
Homozygosity for the G allele 
was associated with better 
outcome. 
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PET examination and 
any somatic or 
neurologic disorder 
that could be expected 
to influence the 
outcome of the study. 
 
Gut-
knecht; 
2007 
German patients 
diagnosed with cluster B 
(133/183; 35.3±13.0 yrs) 
or cluster C (39/65; 
38.5±12.7 yrs) 
personality disorder 
using SCID-II. A 
subgroup of 166 pts also 
had anxiety-related 
comorbidity comprising 
neurotic, stress-related or 
somatoform disorders. 
Inclusion criteria: 
diagnosis and age=18-
60. Exclusion criteria: 
medical conditions that 
have significantly 
changed the previous 
level of functioning, 
lifetime diagnosis of 
psychotic disorders. 73% 
of the pts also had a 
DSM-IV axis I 
diagnosis. 
 
German controls 
(89/247; 22.4±5.3 yrs). 
420 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
336 
Pairwise 
linkage 
disequilibri
um analysis 
 
Allele 
frequency 
analysis in 
pts vs HC 
 
Personality 
measures 
rs4570625 
 
 
 
rs11178997 
 
T allele frequency was higher in pts 
with anxiety-related disorders 
(n=166) relative controls. 
 
T allele frequency was higher in pts 
with adjustment disorders (n=99) 
relative controls. 
 
No sig. differences in allele 
frequency in pts.  relative controls 
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Personality measures 
were taken with German 
versions of the NEO-PI-
R and the TPQ. 
 
Note. a: yrs = years , b: LD =  linkage disequilibrium 
Table 2-2: Summary of studies investigating the link between panic disorder and 
TPH2 polymorphisms. 
 
First 
author; 
year 
Participants 
(male/female; mean 
age) 
n Measurements SNP Association 
Campos; 
2010 
Caucasian bipolar 
pts (82/203; 
41.9±12.3 yrsa) 
diagnosed with 
MINI-PLUS. A 
subgroup of 45 pts 
had lifetime PD 
comorbidity (6/39; 
yrs). Exclusion 
criteria: history of 
alcohol and drug 
abuse and 
dependence. 
274 
 
 
 
 
 
 
 
 
241 
Bipolar pts 
with PD 
comorbidity 
vs controls 
 
Bipolar 
patients with 
PD 
comorbidity 
vs Bipolar 
patients 
without PD 
comorbidity 
rs4448731 
 
 
 
rs4565946 
 
 
 
 
rs11179000 
 
 
 
Higher frequency of the T allele 
and T/T genotype in BPD pts with 
PD  relative controls and BPD pts 
with  relative without PD 
Higher frequency of the C allele 
and CC genotype (p = 0.058; 
PMT) in BPD pts with PD  relative 
controls and BPD pts with  relative 
without PD 
Higher frequency of the T allele in 
BPD pts with  relative without PD 
Higher frequency of the C allele 
and CC genotype in BPD pts with 
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Healthy controls 
(52.6±18.9 yrs) 
 
 
rs4760820 
 
 
 
rs1487275 
 
 
 
rs10879357 
 
 
 
rs7955501  
rs10506645 
PD  relative controls and BPD pts 
with  relative without PD 
Higher frequency of the C allele in 
BPD pts with PD  relative controls 
and BPD pts with  relative without 
PD 
Higher frequency of the A allele 
(PMT) and AG genotype (p = 
0.063; PMT) in BPD pts with PD  
relative controls. 
Higher frequency of the A allele 
and AG or AA genotype (PMT) in 
BPD pts with  relative without PD 
 
No sig differences in allele 
frequency or genotype in all 
analyses 
 
Higher frequency of the 
rs4448731-rs4565946 T-C 
haplotype in BPD pts with  relative 
without PD 
Lower frequency of the 
rs4448731-rs4565946 C-T 
haplotype and the rs10506645-
rs4760820 C-C haplotype in BPD 
patients with  relative without PD 
Kim; 
2009 
Unrelated Korean 
patients (50/58; 
41.8±10.1 yrs) 
diagnosed with 
108 
 
 
 
Pts vs 
controls 
 
Pts vs 
rs4570625 
 
Higher frequency of the G allele 
in: 
- Pts  relative controls 
- Female patients relative female 
42 
 
SCID Exclusion 
criteria: comorbid 
mood disorders, 
psychotic disorders 
or other anxiety 
disorders. Severity 
of the patients’ 
symptoms was 
assessed with the 
STAI, PDSS, ASI, 
API and HAMD. 
 
Unrelated matched 
Korean healthy 
controls (122/125; 
39.4±9.0 yrs) 
Exclusion criteria: 
History of personal 
or family psychiatric 
disorders or 
psychotropic 
medication. 
 
 
 
 
 
 
 
247 
controls in 
gender 
subgroups 
 
Male vs 
female  
pts/controls 
 
Symptom 
severity 
controls 
- Male relative  female controls 
 
No sig. difference in allele 
frequency in: 
- Male patients  relative male 
controls 
- Male  relative female patients 
 
No sig. difference in genotype in 
pts  relative controls 
 
Lower frequency of the TT 
genotype in pts  relative  controls 
(p = 0.055) 
 
 
 
Maron; 
2007 
Estonian patients 
(49/164; 37.9±12.6 
yrs) diagnosed with 
the MINI. Patients 
were included with 
comorbid 
agoraphobia (58%), 
major depression 
(51%), bipolar 
213 
 
 
 
 
 
 
 
 
Pts vs 
controls 
 
Pts vs 
controls in 
gender 
subgroups 
 
Pts vs 
rs1386494 
rs1386483 
No sig. differences in allele 
frequency and genotype in pts. 
relative  controls in whole sample 
 
Sig. higher frequency of the 
rs1386494 A allele and the A/G 
genotype in female PD patients 
without comorbidity (n=52) 
relative  female controls. (In the 
43 
 
disorder (14%) and 
other anxiety 
disorders (4%). 
Exclusion criteria: 
Other psychiatric 
comorbidity. 
 
Matched Estonian 
healthy controls 
(91/212; 39.3±13.3 
yrs). Exclusion 
criteria: Personal or 
family history of 
psychiatric 
disorders. 
 
 
303 
controls in a 
subgroup 
without 
comorbidity 
whole sample PD patients without 
comorbidity relative  controls p = 
0.07 for genotype and p= 0.06 for 
allele analysis) 
 
The rs1386494-rs1386483 C-G 
haplotype showed a lower 
frequency (p = 0.07) and the T-A 
haplotype showed a higher 
frequency (p = 0.05) in female 
patients without comorbidity 
relative female controls. 
Mossner; 
2006 
Unrelated German 
patients (49/85; 
45.7±11.4 yrs) 
diagnosed with 
SADS-LA, CIDI 
and IDCL. 
Comorbidity with 
other anxiety 
disorders or 
depressive disorder 
was allowed as long 
as panic disorder 
was predominant. 
 
Unrelated German 
controls (45.2±10.2 
134 
 
 
 
 
 
 
 
 
134 
Pts vs 
controls 
rs4570625 
 
 
 
rs4565946 
 
No sig. difference in allele 
frequency and genotype in pts 
relative  controls 
 
No sig. difference in allele 
frequency and genotype in 
agoraphobic pts relative  control 
44 
 
yrs) matched for 
gender and age. 
Controls were not 
screened for 
personal or family 
history of 
psychiatric disorders 
 
 
Table 2-3: Summary of studies investigating the link between OCD and TPH2 
polymorphisms. 
 
First 
author; 
year 
Participants 
(male/female; 
mean age) 
n Measurements SNP Association 
2011; 
Rocha 
Brazilian-Caucasian 
pts (18-65 yrsa) 
diagnosed using the 
MINI-PLUS. 
Exclusion criteria: 
major depression, 
bipolar disorder, 
substance-related 
disorder, psychotic 
disorder, lifetime 
history of traumatic 
/ vascular brain 
injury 
 
Brazilian-Caucasian 
107 
 
 
 
 
 
 
 
 
 
214 
Pts vs controls rs4448731 
rs4565946 
rs11179000 
rs7955501 
rs10506645 
rs4760820 
rs1487275 
rs10879357 
No sig. difference in allele 
frequency or genotype 
between pts and controls. 
 
Higher frequency of the 
rs448731-rs4565946-
rs10506645 T-C-T and the 
rs4565946-rs7955501-
rs10506645 C-A-T 
haplotypes in pts relative  
controls 
45 
 
matched controls 
screened using the 
MINI-PLUS. Free 
of psychiatric 
illness and no 
family history of 
Axis I psychiatric 
disorder. 
2005;  
Mössner 
71 German families 
of children (41/30; 
13.29±2.6 yrs) 
diagnosed using the 
C-YBOCSc. 
Comorbid disorders 
were assessed using 
DIPSd. All pts had 
received in-patient 
treatment at the 
University of 
Aachen. Exclusion 
criteria: lifetime 
history of psychotic 
disorder, Tourette’s 
syndrome, autistic 
disorder, alcohol 
dependence, IQ<70 
and if obsessive 
compulsive 
symptoms occurred 
only as part of 
another  disorder. 
71 TDTb rs4570625 
 
 
rs4565946 
 
No preferential allele 
transmission 
 
Preferential transmission of 
the C allele in pts (p = 0.059) 
Higher transmission 
frequency of the CC 
compared to the TT genotype 
 
Preferential transmission of 
the G-C haplotype in pts. The 
G-T haplotype was 
transmitted to pts less 
frequently. 
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Note. a: yrs = years, b: TDT =  transmission disequilibrium test,  c: C-YBOCS = Yale–Brown Obsessive Compulsive Scale 
d: DIPS = Diagnostisches Interview bei psychischen Sto¨rungen im Kindes- und 
Furthermore polymorphisms in the promoter region of the TPH2 gene have 
been reported to be associated with personality traits of harm avoidance and 
disorders related to emotional dysregulation in healthy samples (Gutknecht et al., 
2007; Reuter, Ott, Vaitl, & Hennig, 2007). 
3. Anxiety, Serotonin and Gender 
As indicated above, epidemiological findings reveal a gender difference in 
anxiety: females are predisposed to experience anxiety more likely than males 
(American Psychiatric & American Psychiatric Association. Task Force on, 2000; 
Yonkers, Bruce, Dyck, & Keller, 2003).  Given the role of 5-HT in anxiety, one of 
the explanations accounting for this difference in prevalence may be related to 
gender differences in the regulation of 5-HT.  For instance, an in vivo Positron 
Emission Tomography (PET) study has shown that the rate of 5-HT synthesis in 
healthy males is 52% higher than in healthy females (Nishizawa et al., 1997). 
Moreover; females show a greater behavioral response to acute tryptophan 
depletion procedures (Booij, van der Does, Haffmans, Spinhoven, & McNally, 
2005; Booij et al., 2002). These results pointed to the importance of studying 
gender differences in the occurrence of anxiety disorders, as a function of 5-HT 
genotypes. This however has to our knowledge not been investigated yet. 
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4. Summary 
Dysregulation of the serotonergic system has been shown to be an 
important factor in the pathophysiology of several psychiatric diseases. In the 
previous sections we have focused on several researches showing an association 
between 5-HT polymorphisms and anxiety disorders. However, as indicated in the 
tables above, research is not always consistent. With regard to HTR2A two animal 
studies demonstrated a relation between HTR2A and anxiety-related behavior or 
anxiety disorders. In the human studies, whereas two studies demonstrated a 
relation between HTR2A and anxiety disorders in the clinical samples (Inada et al., 
2003; Maron et al., 2005) two other studies found no association (Fehr et al., 
2001; Rothe et al., 2004). Regarding the TPH2 gene, conflicting results were 
found in human studies. While two studies did not show significant associations 
between TPH2 and anxiety disorders (Mossner et al., 2006; Staals et al., 2011) 
other three studies demonstrated a relation between TPH2 and anxiety disorders 
association(Lin, Ko, Chang, Yeh, & Sun, 2009; Maron et al., 2007). A limitation 
of these studies however is that the majority of them measure anxiety at a single 
point in time, are cross-sectional and most of the studies are in adults. Thus, the 
role of 5-HT genes in the longitudinal developmental course of anxiety is not 
known. Compared to cross-sectional studies, longitudinal studies have clear 
advantages, especially when they are based on representative community sample 
followed over a long period of time (from childhood to adulthood) with multiple 
measurements over a long period of time. Hence, a strength of the current study 
was its longitudinal design, allowing having multiple measures of anxiety and 
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careful investigation of the developmental course in behaviors, over a long period 
of time.  
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Objectives 
The aim of the present study was to investigate the relationships between 
developmental patterns of anxiety in childhood/adolescence, 5-HT genes and the 
development of psychopathology in adulthood, using a longitudinal design with a 
focus on the 5-HT2A gene polymorphisms as well as TPH2. Specific aims were to: 
A) Examine the association between specific 5-HT2A and TPH2 polymorphisms 
and trajectories of anxiety in childhood and adolescence.  Since most of the 
specific polymorphisms available in the investigated sample have not been tested 
yet in other studies, no specific hypotheses in terms of direction of effect can be 
defined. 
B) Examine whether a trajectory of anxiety in childhood-adolescence predicted 
clinical diagnosis in adulthood. 
C) Examine the association between 5-HT2A and TPH2 polymorphisms and 
clinical diagnosis in adulthood. It was examined whether polymorphisms of the 5-
HT2A and TPH2 gene could predict anxiety disorders in adulthood. 
D) Gender differences were tested. 
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Study sample 
Hypotheses were tested in participants of a longitudinal study on 
Kindergarten Children in Quebec (ELEMQ). The community sample was 
representative from all Quebec regions, including both rural and urban areas. This 
cohort consists of 3185 boys and girls (1669 boys and 1516 girls) selected in 1986 
and 1987 from Kindergartens in Quebec’s (Canada) French speaking schools. 
Participants had been followed extensively from age 6 to age 14, and at regular 
intervals until adulthood. Most of participants (82.9%) were living with both 
biological parents and the remaining 17% were living within other family 
structures. The mothers of the participants have completed an average of 11.79 
years of schooling, and the mother`s mean age at birth of their first child was 
24.54 (SD = 3.83).  5-HT genotyping data are available for 1068 cohort members, 
of who were 436 boys and 632 girls. The study was approved by research ethics 
boards of the CHU Saint-Justine and the University of Montreal. Written 
informed consent was obtained from all participants. 
Developmental trajectories of anxiety 
Items of the Social Behavior Questionnaire (SBQ) (Tremblay et al., 1991)  
were used to assess children’s anxiety. The SBQ is a 38 item questionnaire which 
has been divided into four components: a) disruptiveness b) anxiety c) inattention 
and d) prosocial (Tremblay et al., 1991). 
Children’s anxiety was rated by means of the SBQ by their teachers when they 
were in kindergarten and continued over the next seven years while they attended 
elementary school. 
52 
 
For anxiety, the following items were scored by their teachers: worries (worries 
about many things); fearfulness tendency (fearfulness or afraid of new things or 
new situation); cries easily. 
Seven yearly assessments of anxiety symptoms between ages 6 and 14 were used 
to estimate the behavioral trajectories. 
The trajectory of anxiety was modeled on a group-based semi parametric 
mixture method. This semi parametric mixture method is suited to assess 
population heterogeneity over time considering the behavior (Jones, Nagin, & 
Roeder, 2001; Nagin, 1999). The model describes the shape of trajectory for each 
group and estimates the probability of belonging to a group for each individual. 
Using this model, the following developmental trajectories were identified for 
anxiety (Figure 4): a) Low level of anxiety (29.6 %, 942 boys/girls) b) Moderate 
level of anxiety (61.5 %, 1958 boys/girls) c) High level of anxiety (8.9%, 285 
boys/girls). Figure 4 below shows the development trajectory of anxiety in these 
participants based on age and semi-parametric model outcome.  The low anxiety 
trajectory consisted of 480 boys and 462 girls of cohort members, 1039 boys and 
919 girls of members were in moderate level anxiety trajectory and the high 
anxiety trajectory consisted of 150 boys and 135 girls. 
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Figure 4: Development trajectories of anxiety, between age of 6 and 12 years. 
 
 
* group = grp 
Diagnostic Interview Schedule for Adults (DIS) 
In early adulthood (age 21), participants were diagnosed in accordance to 
the Diagnostic and Statistical Manual of Mental Health Disorders, Third 
Edition(American Psychiatric. A., 1987). Mood, substance abuse disorders and 
anxiety (generalized anxiety, panic and phobias) were assessed through an 
interview by psychology students who had experience using the DIS. A total of 
1085 cohort members were interviewed in which 239 of them were diagnosed 
having anxiety disorders (general anxiety, panic and phobias). Only anxiety 
disorders (having either GAD, PD or phobia) were analyzed in the present thesis. 
Genotyping 
In the current study we analyzed a total of 37 single nucleotide 
polymorphism (SNPs) within the 5-hydroytryptamine receptor 2A (HTR2A) and 
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tryptophan hydroxylase-2 (TPH2). Specific polymorphisms were determined 
based on a literature review (Brezo et al., 2010). Using HapMap data for the Utah 
residents with Northern and Western European ancestry and Tagger`s 
multimarker-tagging procedure (r 2> 0.8), common tag SNPs (minor allele 
frequency (maf) > 5%) were chosen for each gene.  SNPs located up to 5 kbp 
upstream of the transcription site (maf  > 5%)(Brezo et al., 2010). For more 
specific literature for the HTR2a and TPH2 gene, see page 31-43. 
Statistics 
In order to examine the influence of TPH2 and HTR2A on the trajectory of 
anxiety in detail, two approaches were applied based on two key outputs of the 
model: a) the estimated proportion (probability) of children belonging to each 
trajectory (continuous approach), and b) the similarities in the shape of their 
trajectory (categorical approach). 
Continuous approach 
Prior to analyses, statistical assumptions were tested using the Shapiro-
Walk test and by visual inspection using histograms (normality assumption) and 
Levin’s test (homogeneity of variance assumption). Data transformation (logit) 
was applied on the probability data since these data were highly-skewed. 
However, untransformed values are displayed in the text and graphs to facilitate 
interpretation. One-way analyses of variance (ANOVAs) were used to test for 
differences in probability to be in the high anxiety trajectory across genotypes, 
using the probability to be in the high anxiety trajectory as dependent variable and 
genotype as between-subjects factor. For all analyses, post-hoc tests for multiple 
55 
 
comparisons were conducted in case of three group analyses. Values are 
expressed as mean (± SD). 
Categorical approach 
Data were analyzed by chi-square tests in order to assess the link between 
genotypes and the anxiety trajectories. Next, two sets of logistic regression 
analyses were performed. First we analyzed the association dichotomously.  
Specifically, the extreme group(s) of the trajectory was compared with the other 
group(s) (dichotomous dependent variable) across the genotypes (independent 
variable) using binary logistic regression. Also the moderate anxiety group was 
compared with the two extreme groups. Thus, the following three associations 
were analyzed: a high anxiety group contrasted with a combined low/moderate 
group; a low anxiety group contrasted with a combined high/moderate anxiety 
group; and a combined low/high anxiety group contrasted against a group of only 
moderate anxiety cohort members. 
Secondly, using multinomial logistic regression (allowing more than two 
categories as dependent variable) we analyzed the association between 
membership in three trajectory groups (dependent variable) and genotypes 
(independent variable). 
Finally, we used a binomial logistic regression model to predict later 
diagnoses of anxiety disorders. We used the diagnosis of anxiety disorders 
(whether or not participant had been diagnosed with GAD or PD or phobias) as 
dependent variable and analyzed the association within polymorphisms (genes) as 
independent variable. By using an additive interaction model in logistic regression 
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we also evaluated whether the magnitude of the association between genes-
anxiety differs across gender. 
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Relationship between 5-HT genes and anxiety trajectories 
As described in the previous section, the relationship between 5-HT genes, 
specifically HTR2A and TPH2, and anxiety trajectories were analyzed using both a 
continuous approach and categorical approach. First we applied a continuous 
approach in order to find the effects of genotype on the probability to be in the 
high anxiety trajectory. Then the categorical approach was used to a) investigate 
differences in genotype distribution between the different anxiety trajectories, b) 
investigate if membership in trajectory groups in childhood could predict clinical 
diagnoses of anxiety in adulthood c) examine the association between genotype 
and clinical diagnosis in adulthood and d) examine the gender differences. 
Continuous approach 
Effects of genotype on probability of high anxiety 
Overall ANOVAs analyses for HTR2A, demonstrated a significant effect of 
one SNP (rs1328684) on the probability of being in the high anxiety trajectory (F 
(2, 1067) = 3.225, p =.039).  Post-hoc analyses with a Tukey correction showed 
that homozygous carriers of genotype C/C (M = .179, SD = .029) were more 
likely to be in the high anxiety trajectory than carriers of T/C (M =.079, SD = 
.008). There were no differences between C/C and T/T and T/C and T/T. 
Allelic similar analysis of SNPs rs1328684 (T/C+C/C vs. C/C; F (1, 1066) 
= 6.443, p = .011) and rs95534511 (C/C+T/C vs T/T; F (1, 1066) = 4.105, p = 
.043) also showed significant associations with the probability of high anxiety.  
Specifically, for rs1328684, children carrying at least one C allele (C/T, C/C: M 
=.176, SD = .029) had a greater probability to be in the high anxiety trajectory 
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than children homozygous for T allele (T/T: M = .090, SD = .006). For 
rs95534511, children homozygous for T allele (M = .112, SD = .015) had a 
greater probability to be in the high anxiety trajectory than children with two C 
alleles (M =.095, SD = .007).  There were no other group differences on any of 
the investigated 5-HT2A genotypes (Figure 5-1). 
When similar analyses were repeated for TPH2, the tag SNPs rs11179050 
(F (2, 1065) = 2.747; df = 2; p =.070) and rs11179052 (F (2, 1066) = 2.664; p 
=.077) approached significance associations on high anxiety probability. 
Specifically homozygosity for the C allele (M = .130, SD =.019) in rs11179050 
was associated with a greater probability to be in high anxiety group than 
homozygosity for the T allele (M =.083, SD = .009, p = .043).  By contrast, for 
rs11179052, locus T/T carriers (M =.134, SD =.093, p = .047) had a greater 
probability to be in high anxiety group than C/C carriers (M =.086, SD =.008) 
(Figure 5-2).  No other differences for any of the other TPH2 polymorphisms were 
found. 
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Figure 5-1: Probability to be in the high anxiety trajectory, as a function of 5-
HT2A genotype rs1328684 (a) and rs95534511 (b). Probabilities are expressed in 
percentages. 
a) 
 
b) 
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Figure 5-2:  Probability to be in the high anxiety trajectory, as a function of TPH2 
genotype rs11179050 (a) and rs11179052 (b). Probabilities are expressed in 
percentages. 
a) 
 
b) 
 
Categorical approach 
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Effect of genotype on anxiety trajectory classification 
Chi-square statistics showed significant differences in the genotype 
frequencies (across anxiety trajectories) for three SNPs of HTR2A; rs7330636, 
rs1745837 and rs1328684. For both HTR2A rs7330636 and rs1745837 variants, 
individuals in the high anxiety trajectory group were more often carriers of the 
A/G genotype than the G/G and A/A genotypes. For HTR2A SNP rs1328684, 
individuals in the high anxiety trajectory group had more often the T/T genotype 
than genotype T/C and C/C (See Table3). Among the investigated TPH2 SNPs, 
only rs1386498 showed statistically significant associations with the anxiety 
trajectories. Specifically, individuals in the high anxiety trajectory group had more 
often the T/C genotype than genotypes C/C and T/T (see Table 3). 
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Table 3: Distribution of genotype frequencies of HTR2A and TPH2 
polymorphisms as a function of anxiety trajectory (percentage of genotype 
frequency). 
 
 SNPs Genotype frequency distribution within  low, moderate 
and high anxiety trajectory (%) 
χ 2 P 
HTR2A rs7330636 Genotype 
low/moderate/high 
A/G                     A/A                  G/G 
(51/44/55)         (13/19/12)       (35/37/34) 
10.140 .038 
HTR2A rs1745837 Genotype 
low/moderate/high 
A/G                     A/A                  G/G 
(41/39/46)         (53/52/40)       (6/10/14) 
9.783 .044 
HTR2A rs1328684 Genotype 
low/moderate/high 
T/C                      C/C                  T/T 
(45/48/32)         (8.5/9/23)        (47/43/45) 
18.688 .001 
TPH2 rs1386498 Genotype 
low/moderate/high 
T/C                      C/C                  T/T 
(48/42/56)         (34/41/31)       (18/17/13) 
9.583 .048 
 
Next, a series of logistic regression analyses were conducted to test further 
the association between genotypes and trajectories. Contrasts between the 
trajectories groups were distinct in the way that a combination of two groups 
could be compared to a third, reference group. Thus the combined low and 
medium trajectory group was compared with the high anxiety trajectory group. 
Analysis of HTR2A- The analysis showed significant associations between HTR2A 
rs1745837, rs1328684, rs7984966 and membership in the high anxiety trajectory 
versus low+ medium group. Specifically, there was a significant association 
between rs1745837 and membership in the high trajectory relative to the low-
medium group.  Individuals who were homozygous for the A allele were more 
often in the high anxiety trajectory group compared to those that were G 
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homozygotes (A/A vs. G/G, β = .824, SE = .357, Wald = 5.313, p = .021).  Also 
for rs1328684, genotype C/C predicted membership in the high anxiety group 
compared to genotype T/T or T/C (C/C vs T/T, β = .903, SE = .304, Wald = 
8.818, p = .003; C/C vs T/C, β = 1.282, SE = .321, Wald = 15.953p = .001) 
Another significant association was found between HTR2A variant rs 
7984966 and the high anxiety trajectory. Specifically the analysis demonstrated 
that carriers of homozygous C/C were more likely to be in the high anxiety group 
than carriers of T/T (C/C vs T/T, β = .790, SE = .367, Wald = 4.633, p = .031).  
Analysis of TPH2- For TPH2, significant associations between rs10748185, 
rs11179050, rs11179052, rs 11179056 and membership in the high anxiety 
trajectory relative to the low-medium anxiety group were found. 
For SNP rs10748185, genotype A/G predicted membership in the high 
anxiety group compared to the genotype A/A (A/G vs A/A, β 
SWald p = .012).  Also, for rs11179050, children 
who were homozygous for the T allele were more often in the high anxiety 
trajectory than those who were homozygous for the C allele (C/C vs T/T, β = .672, 
SE = .334, Wald = 4.036,  p = .045). In contrast, for rs11179052, individuals who 
were homozygous for C are more likely to be in the high anxiety group than 
children were homozygous for the T allele (T/T vs C/C, β = .649, SE = .324, Wald 
= 3.890, p = .049).  Finally, for rs11179056, carriers of the G/G and A/G 
genotype were more often in the high anxiety trajectory than carriers who were 
homozygous for the A allele (A/A vs G/G, β = 2.084, SE = .921, Wald = 5.118,   
p = .024, A/G vs A/A, β = 2.030, SE = .961, Wald = 4.448, p = .035). 
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Anxiety trajectories and clinical diagnosis in adulthood 
We analyzed whether membership in trajectory groups in childhood were 
associated with anxiety disorders at age 21. Chi-square analyses showed that there 
was no association between trajectories of anxiety in childhood / adolescence and 
anxiety diagnosis in adulthood (2 = 1.852, p = .396). 
5-HT genes and clinical diagnosis 
Binomial logistic regression models showed that the genotype 
distributions were significantly different between those with and without an 
anxiety diagnosis for HTR2A, rs3125, rs9567739, rs1885884, rs2224721 and 
TPH2, rs4760820. Specifically, for SNP rs3125, genotype G/G or G/C predicted a 
diagnosis of anxiety compared to genotype C/C (G/G vs G/C, p =.015; G/C vs 
C/C, p = .026) (for complete statistics see Table 4). 
Also for rs9567739 and rs1885884 carriers of C/G were more likely to be 
diagnosed with an anxiety disorder compared to carriers of homozygous C allele 
and G allele consecutively (C/G vs C/C, p = .031; C/G vs G/G,  p = .036).  
Finally for HTR2A rs2224721, anxiety disorders were associated with the A/C 
genotype compared to the A/A genotype (AC vs AA, p = .015). For TPH2 
polymorphism rs4760820, analysis showed that the carriers of two C alleles and 
were less likely to be diagnosed with an anxiety disorder than carriers of the G/G 
genotype (C/C vs. G/G, p = .048) (see Table 4). 
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Table 4:  Logistic regression analyses, predicting anxiety diagnosis in adulthood 
from HTR2A and TPH2 genotypes. 
 
 SNPs 
genotype 
β SE Wald p 
HTR2A rs3125 
C/C vs G/G 
C/C vs G/C 
 
1.19 
1.14 
 
.49 
.51 
 
5.87 
4.98 
 
.015 
.026 
HTR2A rs9567739 
C/G vs C/C 
 
.45 
 
.18 
 
4.78 
 
.031 
HTR2A rs1885884 
G/C vs G/G 
 
.35 
 
.19 
 
4.80 
 
.036 
HTR2A rs2224721 
A/C vs A/A 
 
.47 
 
.17 
 
5.36 
 
.015 
TPH2 4760820 
C/C vs G/G 
 
- .47 
 
.23 
 
3.90 
 
.048 
 
 
Note: There were no associations between anxiety diagnosis and other TPH2 and 
5-HTR2A polymorphisms. 
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Gender differences 
Effect of genotype on anxiety trajectory classification 
The association between genotype distributions and anxiety trajectories 
were significant when looking separately in boys and girls for three HTR2A SNPs 
and one TPH2 polymorphism (see Table 5 and Table 6). 
For boys, the association between anxiety trajectory and genotype 
distribution of three HTR2A rs1928042, rs9316235, rs1328684 (χ2 = 2.976, p = 
.020), (χ2 =10.998, p = .027), (χ2 = 9.732, p = .045) variants and one TPH2 
polymorphism rs11179000 (χ2 = 10.47, p = .047) were significant.  Specifically, 
in children characterized by a high anxiety trajectory, the prevalence of rs1928042 
genotype A/A was 9-fold higher than the genotype C/C and ~ 3-fold higher than 
genotype A/C.  For variant rs9316235, carriers of homozygous G were more 
likely to be in the high anxiety trajectory than carriers of the A/G and A/A 
genotype. Also for SNP rs1328684, boys who were homozygous for T allele were 
more often in the high anxiety trajectory than boys with at least one C allele.  For 
TPH2 rs11179000, boys with T/T genotype were more often in the high anxiety 
trajectory than boys with the T/A genotype. 
In contrast, in girls, three THP2 SNPs rs11179050, rs1487275, rs11179052 
(p = .046, χ2 = 9.583), (p = .035, χ2 = 10.374), (p = 0.025, χ2 =11.55)   and only 
one HTR2A variant rs1328684 showed significant associations between genotype 
and anxiety (see Table 6).  Specifically the analyses for the TPH2 gene indicated 
that for rs11179050, girls with T/C genotype were more frequent in the high 
anxiety group than girls who were homozygous for the T or C allele. For SNP 
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rs1487275, girls homozygous for C/C were more likely to be in the high anxiety 
trajectory than girls with the A/C and A/A genotype. In addition, for TPH2 variant 
rs11179052, girls with the T/C genotype were for often in the high anxiety 
trajectory than girls who were homozygous for the C or for the T allele.  A similar 
effect was seen for girls for rs1328684, with a greater prevalence of the T/C 
genotype in girls with a high anxiety trajectory compared to the T/Tor C/C 
genotype. 
Table 5: Distribution of genotypes frequencies of HTR2A and TPH2 
polymorphisms within low,   moderate and high anxiety trajectories in boys 
(percentage of genotype frequency), p < .05 
 
 SNPs Genotype frequency distribution within low, moderate and 
high anxiety trajectory for boys (%) 
Chi-sq. p 
HTR2A rs1928042 Genotype 
low/moderate/high
A/C                        A/A                      C/C 
33/44.5/25        64/51/67.5               2.5/4/7.5 
2.976 .020 
HTR2A rs9316235 Genotype 
low/moderate/high
G/G                         A/G                     A/A 
57.5/59/62.5       36/38/22.5              6/3/15 
10.998 .027 
HTR2A rs1328684 Genotype 
low/moderate/high
T/T                           T/C                    C/C 
47/38/57.5         45/51/27.5              8/11/15 
9.732 .045 
TPH2 rs11179000 Genotype 
low/moderate/high
T/T                          T/A                     A/A 
58/60/72.5         35/38/27.5                7/2/0 
10.47 .047 
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Table 6: Distribution of genotypes frequencies of HTR2A and TPH2 within low, 
moderate and high anxiety trajectories in girls (percentage of genotype 
frequency), p < .05 
 
 SNPs Genotype frequency distribution within low, moderate and 
high anxiety trajectory for girls (%) 
Chi-  Sq. P Girl 
HTR2A rs1328684 Genotype 
low/moderate/high 
T/T                    T/C                     C/C 
(47/47/34)      (44/45/36)         (9/8/29.5) 
19.721 .001 
TPH2A rs11179050 Genotype 
low/moderate/high 
T/T                    T/C                     C/C 
(40/37/27)      (50/47/48)         (10/17/25) 
9.583 .046 
TPH2A rs1487275 Genotype 
low/moderate/high 
C/C                    A/C                    A/A 
(53/51/45.5)   (43.5/42/39)      (3.5/7/16) 
10.347 .035 
TPH2 rs11179052 Genotype 
low/moderate/high 
C/C                    T/C                     T/T 
(43/42/36.5)    (48.5/42.5/39)  (9/15.5/25) 
11.155 .025 
 
 
Additive effect of gender on genotype and anxiety trajectories 
Finally, we estimated the interaction on an additive scale between gender 
differences and genotype on membership in high anxiety group by a logistic 
regression model. There was “negative” interaction for HTR2A rs1328684 on 
additive scale (β = -1.414, SE = .640, Wald = 4.881 p = .027). Using the Formula 
of RERI (see Knol, van der Tweel, Grobbee, Numans, & Geerlings, 2007  for 
description of RERI), the amount of additive interaction was equal to – 0.24. This 
means that the relative risk of being in high anxiety trajectory group versus low-
medium group was 0.24 less for boys than for girls (for rs1328684). There were 
no other additive interactions with gender. 
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The goal of the present study was to investigate the influence of 5-HT 
gene variation on the development of anxiety during the elementary school years 
(from kindergarten) until adolescence in a large longitudinal community sample 
of children. The first aim was to examine the relationships between thirty-seven 
SNPs within HTR2A and TPH2 genes and anxiety developmental trajectories. The 
second aim was to investigate the association between the 5- HTR2A and TPH2 
genes, anxiety trajectories and clinical diagnosis in adulthood. The third aim was 
to explore gender differences. Trajectories of anxiety were based on teacher 
ratings conducted between the age of 6 and 12 years using the Social Behavior 
Questionnaire. These trajectories were defined as low anxiety trajectory, moderate 
anxiety trajectory and high anxiety trajectory, as described and calculated 
previously (Cote, Tremblay, Nagin, Zoccolillo, & Vitaro, 2002). Out of 37 
investigated polymorphisms, several 5-HTR2A (rs1328684, rs95534511, 
rs1745837, rs7984966, 7330636) and TPH2 (rs11179050, rs11179052, rs1386498) 
polymorphisms were associated with a high anxiety trajectory. 
With regard to the HTR2A gene, the results are remarkably consistent with 
two different animal studies. As described in the introduction of this thesis, one 
study found that global disruption of the function of the HTR2A receptor 
(knockout model) led to an increase in risk behavior in a number of conflict 
anxiety paradigms in mice, while depression-related behaviors remained 
unaffected (Weisstaub et al., 2006). Another study found lower 5-HT2A receptor 
binding index in bilateral frontocortical regions of the brain of sixteen dogs 
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diagnosed with anxiety disorders, relative to 22 normal-behaving dogs (Vermeire 
et al., 2009). 
In humans, polymorphic variation of the HTR2A gene has been assessed in 
relation to anxiety disorders in clinical samples, though with conflicting results 
(Fehr et al., 2001; Inada et al., 2003; Maron et al., 2005; Rothe et al., 2004). For 
instance, two studies found no association between HTR2A (T102C) and anxiety 
disorders (PD, GAD) (Fehr et al., 2001; Rothe et al., 2004). In contrast, two other 
studies (one conducted in Japan and another one in Estonia) demonstrated a 
positive association between HTR2A gene and PD (Inada et al., 2003; Maron et al., 
2005). No previous study has investigated the link between the 5-HTR2A gene and 
anxiety in children, nor in relation to non-clinical levels of anxiety. The present 
study is the first study showing that polymorphic variation in the HTR2A gene is 
associated with variation in anxiety in a non-clinical community sample of 
children. Meta-analytic studies are needed to carefully compare the strength of 
effects across studies. 
In addition, we also found significant associations between TPH2 
(rs11179050, rs11179052, rs1386498) and anxiety trajectories. The relevance of 
the TPH2 gene for brain 5-HT synthesis has previously been demonstrated in 
animals (Zhang et al., 2004) and in humans (Booij et al., 2011).  However, 
researches investigating associations between the TPH2 gene and anxiety are 
inconsistent. Whereas some studies in Caucasians did not demonstrate significant 
associations between anxiety disorders (e.g.; PD, SAD) and TPH2 polymorphisms 
(Mossner et al., 2006; Staals et al., 2011) another study in a Han Chinese 
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population in Taiwan, showed a positive association (Lin et al., 2009). 
Interestingly, in another study (Estonian population), the association between PD 
and TPH2 polymorphisms was limited to female patients (Maron et al., 2007). The 
present study is the first to show the link between TPH2 variation and 
developmental patterns of anxiety in a young sample. Again, future meta-analytic 
studies are needed to compare effect sizes across studies. 
Though trajectories of anxiety in childhood and adolescence did not 
predict any diagnosis at age 21, relationships were found between HTR2A and 
TPH2 SNPs and anxiety diagnosis at age 21. Interestingly, the SNPs for which we 
found associations with clinical anxiety diagnosis (HTR2A: rs3125, rs9567739, 
rs1885884, rs222472, TPH2: rs4760820) were not the same as the ones for which 
we found associations with developmental trajectories of anxiety assessed in 
childhood. This suggests that the genetic predisposition to develop anxiety in 
childhood may not be the same as the genetic predisposition to develop anxiety 
disorder in adulthood. No other studies were found that made such comparison 
directly. However, the findings of the present study are consistent with the 
observation that the core diagnostic criteria of anxiety might be different across 
children and adults. The present observations highlight to use special assessment 
and treatment strategies for this age group (Beesdo et al., 2009).  
Interestingly, the association between HTR2A and TPH2 genes and anxiety 
was different for boys and girls. Specifically, there was generally a stronger 
association between the high anxiety trajectory and TPH2 genotype for girls than 
for boys. Whereas three TPH2 SNPs (rs11179050, rs1487275, rs11179052) were 
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associated with the high anxiety trajectory in girls, just one THP2 variant 
rs11179000 demonstrated this association in boys. These results are consistent 
with a study of Maron et al., showing an association between TPH2  rs1386494 
and PD in adult female patients whereas there was no such association for male 
patients (Maron et al., 2007). Interestingly, while for TPH2 the effects were 
stronger for girls than for boys, the opposite was observed for HTR2A in our study.  
The evidence from different studies suggests that the impact of genetic factors on 
anxiety risk differ for men and women. Interestingly, gender also plays a role in 
responses to pharmacological treatment for anxiety disorders (Kinrys & Wygant, 
2005). Furthermore, women are more responsive to serotonergic challenge 
procedures (Booij et al., 2002; Booij et al., 2005). The finding that the effects of 
the TPH2 gene on behavior as observed in the present study is greater in females 
than in males is in line with the observation that women have lower brain 5-HT 
synthesis than males (Nishizawa et al., 1997). Although speculative, genetic 
factors may play a more prominent role in the production of serotonin in females 
than in males, while other factors known to affect brain serotonin synthesis, such 
as the environment (Booij et al., 2012) may be more crucial for the brain 
serotonin production in men. A reverse mechanism may exist for the receptor 
gene. There are no studies however that compared the genetic and/or 
environmental contribution in serotonin neurotransmission between males and 
females, and future studies should investigate this further. Nevertheless, the 
results of the present study suggest that it is important to take gender into account 
when analyzing associations between serotonergic genes and behaviors. 
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Though the underlying mechanism remains unknown, these results demonstrated 
the importance of taking into account gender in the investigation of the link 
between 5-HT genes and anxiety. 
The present study had a number of strengths. To our knowledge, this study 
was the first to investigate the association of HTR2A and TPH2 genes with the 
developmental course of anxiety trajectories in a community sample.  Moreover, 
most previous studies on the role of 5-HT genes in anxiety disorders were cross-
sectional and were done in adult patients; therefore they revealed little 
information about the genetic underlying of the developmental pattern of anxiety.  
In addition, when using trajectories our analyses were based on multiple 
measurements of anxiety, rather than an anxiety measurement taken at a single 
point in time. This may have provided a better understanding of natural course of 
anxiety symptoms.  Finally, this is one of the few studies taking gender 
differences into account. 
The present study has the following limitations. First, we did not take into 
account the influence of environmental factors.  Several studies show 5-HT gene 
X environmental interactions in the prediction of clinical diagnosis (Booij et al., 
2011; Caspi et al., 2005).  Exposures to environmental factors such as stressful 
life events, major health problems, childhood maltreatment and even 
socioeconomic factors have been associated with increased risk for anxiety and 
also interact with different genetic variants to predispose to aggression(Craig, 
2007; Kim-Cohen, Moffitt, Taylor, Pawlby, & Caspi, 2005; Moffitt, 2005). 
However, in healthy samples, a number of studies have shown main effects of 
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genes on behavioral traits in nonclinical samples, while gene X environmental 
interaction effects were minimal or absent (Verhoeven, Booij, Kruijt, Cerit, & 
Van der Does, Manuscript in preparation). Nevertheless, even though adversity 
was expected to have a small effect on the outcome in this sample, it would be of 
interest to investigate these interactions further. Secondly, the diagnosed adult 
sample was covering PD, GAD and phobias together and because of sample size 
we did not have the statistical power to investigate associations between 5-HT 
genes and the specific anxiety diagnosis. Thus the relationships between 5-HT 
genes and PD, 5-HT and GAD, 5-HT and phobias specifically was not assessed. 
Third, although a candidate gene approach offer a powerful way of investigating 
possible genetic linkage directly, candidate gene studies, including the present 
study, typically involve a multitude of analyses, potentially causing many false 
positives. As we included a large number of polymorphisms in our study for 
exploratory purposes, as it is the case for many published candidate gene studies, 
power was insufficient to correct for multiple comparisons. Consequently, we 
cannot rule out the possibility of type I errors. Additional studies are needed to 
further replicate these findings. 
Importantly, the functional relevance of most of the SNPs investigated in 
the present study should be further investigated. The potential functional role of 
some TPH2 variants has been shown in several previous studies. Most of the 
evidence is related to the G1473A polymorphism, showing that homozygous 
carriers of the 1473G mutant had lower 5-HT synthesis in the frontal cortex and 
striatum (Zhang et al., 2004). However in humans this mutant is rare, if not absent 
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(Booij et al., 2011). In a recent study the possible role of some intronic TPH2 
variants for human brain 5-HT synthesis in the orbitofrontal cortex was 
investigated (Booij et al., 2011). The functional relevance of the TPH2 variants 
tested in our study however is yet unknown. 
Regarding the functional relevance of HTR2A, studies in post-mortem brain 
samples demonstrated an association between genotype 1438A/G and 5-HT2A 
receptor expression (Myers, Airey, Manier, Shelton, & Sanders-Bush, 2007). 
Whereas some studies showed the relationship between T-allele of T102C SNP 
and higher 5-HT2A receptor binding (Khait et al., 2004; Turecki et al., 1999) 
others reported no association between 5-HT2A receptor density and genotype (Du 
et al., 1999; Kouzmenko et al., 1997; Kouzmenko et al., 1999). The functional 
relevance of the HTR2A SNPs used in the present study has not yet been 
investigated. Thus, more in vitro and in vivo studies are needed to understand the 
functional relevance of the HTR2A and TPH2 variants in the current study. 
In addition to genetic factors, behavioral, cognitive, interpersonal and 
contextual factors have to be considered for a better understanding of the origin of 
anxiety disorders (Essau & Petermann, 2002; Grahame-Smith, 1964; Vasey & 
Dadds, 2001). Thus prospective-longitudinal studies are necessary to investigate if 
adversity increases the risk for onset of an anxiety disorder in addition of the 
association between 5-HTR2A/TPH2 polymorphisms and development of anxiety 
in childhood. Furthermore, one of the problems of genetic studies is the 
heterogeneity and the types of genetic variation across a certain population (i.e. 
population effect) (Burmeister, McInnis, & Zöllner, 2008; Grahame-Smith, 1964). 
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As the large majority of the present sample was from Québec French speaking 
population, future studies should study whether the effects can be generalized to 
specific other ethnic groups. Finally taking into account that anxiety problems 
often co-occur with other psychiatric problems, future studies should take 
comorbidity into account in the analyses. 
In conclusion, this is the first study reporting an association with HTR2A, 
TPH2 variants and trajectories of anxiety in children. Whereas diagnosis at 
adulthood was not predictive of trajectories of anxiety in childhood, the result of 
this study confirmed the link between some HTR2A and TPH2 polymorphisms and 
diagnosis in adulthood. Moreover, this study also illustrates the importance of 
taking gender into account in genetic analyses. Future studies should replicate the 
findings in larger samples, in individuals with different ethnicities and further 
examine the interaction with early stress. Moreover, the functional relevance of 
the polymorphisms of investigation should be further investigated. 
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